Qilian is a company specializing in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (“TCMD”) product, heparin product, sausage casings, and fertilizers. Founded in 2006, it operates in the industries of Health Care, Manufacturing, and Pharmaceutical. The company received a significant CNY12.00M post-IPO equity investment on 26 May 2015, with contributions from SooChow Securities, Guotai Junan Securities, and Zhongshan Securities. Qilian's diverse product portfolio and recent investment indicate potential for growth and innovation in the health and pharmaceutical sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | CNY12.00M | 3 |
|
26 May 2015 |
No recent news or press coverage available for Qilian.
We care about your data, and we'd love to use cookies make your experience better.